Literature DB >> 33877584

Patient and Provider Insights into the Impact of Multiple Sclerosis on Mental Health: A Narrative Review.

Bryan E Davis1, Lynsey Lakin2,3, Cherie C Binns4, Keisha M Currie5, Mary R Rensel6.   

Abstract

Multiple sclerosis (MS) is a chronic disease in which the immune system attacks the central nervous system, causing inflammation and neurodegeneration. People living with MS may experience a variety of symptoms as a consequence of this process, including many "invisible" symptoms that are internally manifested and not seen by others. Of the invisible symptoms of MS, which we have reviewed in a companion article, mood and mental health disorders are of particular concern due to their high prevalence and significant impact on patient quality of life. In this review, we showcase the experiences of patient authors alongside perspectives from healthcare provider authors as we promote awareness of the common mental health conditions faced by those living with MS, such as depression, anxiety, adjustment disorder, bipolar disorder, psychosis, and suicidal ideation. Many of these conditions stem in part from the increased stress levels and the many uncertainties that come with managing life with MS, which have been exacerbated by the environment created by the coronavirus disease 2019 (COVID-19) pandemic. A patient-centered interdisciplinary approach, routine screening for mental health changes, and referral to specialists when needed can normalize discussions of mental health and increase the likelihood that people living with MS will receive the support and care they need. Management techniques such as robust social support, cognitive behavioral therapy, mindfulness-based interventions, and/or pharmacotherapy may be implemented to build resilience and promote healthy coping strategies. Increasingly, patients have access to telehealth options as well as digital apps for mental health management. Taken together, these approaches form an integrative care model in which people living with MS benefit from the care of medical professionals, a variety of support networks/resources, and self-management techniques for optimal mental health care.

Entities:  

Keywords:  Anxiety; Cognitive behavioral therapy; Depression; Integrative care; Invisible symptoms; Mental health; Mindfulness-based interventions; Multiple sclerosis; Patient experience

Year:  2021        PMID: 33877584     DOI: 10.1007/s40120-021-00240-9

Source DB:  PubMed          Journal:  Neurol Ther        ISSN: 2193-6536


  76 in total

Review 1.  Neuropsychiatric syndromes of multiple sclerosis.

Authors:  Ruth Murphy; Stefani O'Donoghue; Timothy Counihan; Colm McDonald; Peter A Calabresi; Mohammed As Ahmed; Adam Kaplin; Brian Hallahan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-03-11       Impact factor: 10.154

2.  Psychiatric comorbidity is associated with disability progression in multiple sclerosis.

Authors:  Kyla A McKay; Helen Tremlett; John D Fisk; Tingting Zhang; Scott B Patten; Lorne Kastrukoff; Trudy Campbell; Ruth Ann Marrie
Journal:  Neurology       Date:  2018-03-09       Impact factor: 9.910

3.  The Prevalence of Bipolar Disorders and Association With Quality of Life in a Cohort of Patients With Multiple Sclerosis.

Authors:  Adalia H Jun-O'Connell; Ankur Butala; Idanis Berrios Morales; Nils Henninger; Kristina M Deligiannidis; Nancy Byatt; Carolina Ionete
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2016-08-19       Impact factor: 2.198

Review 4.  Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing.

Authors:  Alex J Mitchell; Julián Benito-León; José-Manuel Morales González; Jesús Rivera-Navarro
Journal:  Lancet Neurol       Date:  2005-09       Impact factor: 44.182

5.  Invisible and visible symptoms of multiple sclerosis: which are more predictive of health distress?

Authors:  Carmel Parker White; Mark B White; Candyce S Russell
Journal:  J Neurosci Nurs       Date:  2008-04       Impact factor: 1.230

6.  Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group.

Authors:  Peter Rieckmann; Diego Centonze; Irina Elovaara; Gavin Giovannoni; Eva Havrdová; Jurg Kesselring; Gisela Kobelt; Dawn Langdon; Sarah A Morrow; Celia Oreja-Guevara; Sven Schippling; Christoph Thalheim; Heidi Thompson; Patrick Vermersch; Karen Aston; Birgit Bauer; Christy Demory; Maria Paz Giambastiani; Jana Hlavacova; Jocelyne Nouvet-Gire; George Pepper; Maija Pontaga; Emma Rogan; Chrystal Rogalski; Pieter van Galen; Ali-Frédéric Ben-Amor
Journal:  Mult Scler Relat Disord       Date:  2017-11-21       Impact factor: 4.339

7.  Exploration of Undertreatment and Patterns of Treatment of Depression in Multiple Sclerosis.

Authors:  Aida Raissi; Andrew G M Bulloch; Kirsten M Fiest; Keltie McDonald; Nathalie Jetté; Scott B Patten
Journal:  Int J MS Care       Date:  2015 Nov-Dec

8.  Depressive Symptoms Are Associated With More Negative Functional Outcomes Than Anxiety Symptoms in Persons With Multiple Sclerosis.

Authors:  Sascha Gill; Jonathan Santo; Mervin Blair; Sarah A Morrow
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2018-09-06       Impact factor: 2.198

9.  Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak.

Authors:  Aleksandar Stojanov; Marina Malobabic; Vuk Milosevic; Jelena Stojanov; Slobodan Vojinovic; Goran Stanojevic; Milos Stevic
Journal:  Mult Scler Relat Disord       Date:  2020-07-16       Impact factor: 4.339

10.  Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art.

Authors:  Celeste Silveira; Renato Guedes; Diana Maia; Rosário Curral; Rui Coelho
Journal:  Psychiatry Investig       Date:  2019-12-09       Impact factor: 2.505

View more
  3 in total

1.  PECAM-1 Is Down-Regulated in γδT Cells during Remission, but Up-Regulated in Relapse of Multiple Sclerosis.

Authors:  Michał K Zarobkiewicz; Izabela Morawska; Wioleta Kowalska; Paweł Halczuk; Jacek Roliński; Agnieszka A Bojarska-Junak
Journal:  J Clin Med       Date:  2022-06-04       Impact factor: 4.964

Review 2.  Telemedicine as a strategic intervention for cognitive rehabilitation in MS patients during COVID-19.

Authors:  Fereshteh Ghadiri; Abdorreza Naser Moghadasi; Mohammad Ali Sahraian
Journal:  Acta Neurol Belg       Date:  2022-01-30       Impact factor: 2.471

3.  Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach-perspectives from the International Progressive MS Alliance.

Authors:  Paola Zaratin; Brenda Banwell; Timothy Coetzee; Giancarlo Comi; Anthony Feinstein; Robert Hyde; Marco Salvetti; Kathryn Smith
Journal:  Mult Scler J Exp Transl Clin       Date:  2022-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.